Brainfarma

Director of Government Relations and Regulatory Affairs at Hypera Pharma and pharmacist specializing in Industrial Pharmacy and Clinical Pharmacology, has more than 20 years' experience in the pharmaceutical experience in the pharmaceutical sector, working in national and multinational companies. Since 2018, she has held the position of Director of Government Relations at Hypera Pharma, where she is responsible for institutional relations with public authorities and regulatory strategies. Throughout her career, she has also stood out in industry organizations, reinforcing her role in the areas of public policy and industry regulation. and regulation of the pharmaceutical industry.

Executive Director of Hypera Pharma's similar products and generics business unit, where he leads the operations of the Neo Química brand. Under his management, Neo Química has consolidated itself as the leader in the Brazilian generic drugs market, with sales of 461 million units by 2023, which is equivalent to 878 boxes per minute. In addition to its his work at Hypera, he has stood out in the pharmaceutical sector for his commitment to democratizing access to healthcare. democratization of access to healthcare.